There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

The Israel-Iran clash seemingly has no end in sight — a prospect that does not seem to be panicking the markets.

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Fat steers and heifers filled the pens at the Finney County Fairgrounds in the early morning hours of June 3, waiting to be ...

Citizens Financial Group (CFG) will be expanding its share buyback program to $1.5 billion. Pharmaceutical giant Merck (MRK) ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.

Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...